Clinical Trial

Subconjunctival Humira for Boston Keratoprosthesis

Name: Subconjunctival Humira for Boston Keratoprosthesis — clinical trial record (NCT06926478)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This trial is studying the safety and tolerability of receiving an injection of adalimumab (Humira) during the Boston Keratoprosthesis (KPro) surgery.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-07.

Trial Details

NCT Number	NCT06926478
Lead Sponsor	Massachusetts Eye and Ear Infirmary
Conditions	Penetrating Keratoplasty, Multiple Graft Failure, Ocular Cicatricial Pemphigoid, Stevens-Johnson Syndrome
Enrollment	8 participants
Start Date	2026-06-01
Primary Completion	2027-06-01 (estimated)
Study Completion	2028-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-27